3DM

The smart way to find targets for innovative drug development and biotechnological applications

Focus your efforts on the most suitable protein candidates

3DM is designed to accelerate the development of innovative drugs and therapeutics thanks to quick assessment of novel protein targets. It provides powerful insights of sequence-structure-function relationships through a combination of evolutionary data, 3D structures and relevant literature — allowing you to save time and resources by focusing solely on targets with data-backed potential.

Structure-based sequence alignments

Inform your decisions with reliable data

The robust 3DM dataset is built on high-quality multiple sequence alignments that scale to large protein superfamilies. Highly accurate alignment data gives you solid strategic insights on protein suitability.

Comprehensive evolutionary analysis

Discover functional hotspots and critical residues

With 3DM, explore evolutionary patterns to identify functional hotspots and critical residues in protein structures. This feature aids in understanding protein behavior and potential interactions, providing a deeper layer of insight.

Interactive visual tools

See relationships and structural features

Leverage 3DM’s interactive tools and analytics to visualize evolutionary relationships, structural features, and functional sites of proteins. Boost your ability to interpret complex data and make informed research decisions.

Holistic data integration

Access all relevant information in one place

3DM integrates data from diverse sources, including evolutionary data, protein structures , patents and scientific literature, to provide a holistic view of protein families. This comprehensive approach ensures you have all the necessary information at your fingertips to assess protein targets.

Patent landscape evaluation

Don’t chase dead ends thanks to quick IP insights

Understand what is already claimed at each position with 3DM’s integrated intellectual property analysis. Explore the patent landscape, identify potential sequence space restrictions and opportunities, and let your counsel draw the conclusions: if your candidate protein is already claimed, you’ll know from the start.

Dr. Klara Birikh

“Thanks to 3DM, we were able to bring a novel xylose isomerase to the market, one that is much more robust than all commercially available xylose isomerases. 3DM was instrumental in finding this novel enzyme and in massively improving its substrate preference”

Dr. Klara Birikh, METGEN Oy
Ed Sherer

“The panel design module is a real time saver for us and it’s easy to use. The enzyme selection algorithm results in a very high percentage of expressible enzymes still ensuring great diversity of the enzymes in the panel”

Ed Sherer, Merck & Co
3DM Engineering
Identify promising starter proteins and refine functional properties
3DM Antibodies
Accelerate antibody development with sequence property insights